Showcasing the Best of Welsh Business

DEFAULT GROUP

Creo Medical to Create 85 New Jobs Following £708,000 Welsh Government Investment

SHARE
,

Monmouthshire-based Creo Medical Limited is expanding and creating 85 well-paid jobs over 3 years, thanks to a £708,000 investment from the Welsh Government.

The high technology medical device company specialises in the emerging field of surgical endoscopy, which aids minimally invasive surgery by applying microwave and radio wave energy.

The Chepstow-based company is set to build a new research and development (R&D) manufacturing centre on its current site.

It will use the Welsh Government’s Economy Futures Fund investment to invest in expanding its premises and in state of the art manufacturing equipment.

Innovating new medical technologies for the benefit of patients is a key part of the Welsh Government’s new Innovation Strategy, which was launched in February 2023.

Economy Minister, Vaughan Gething said:

“We are committed to supporting businesses like Creo Medical to innovate with cutting edge technology, which will support improved healthcare while also boosting our economy.

Creo Medical is a well-established company and an important employer in the south-east of Wales. I am delighted our support will help them to grow even further and create so many new high-skilled jobs.

“Our aim is to build a fairer, greener, and more prosperous Wales. Our support for Creo Medical is a further demonstration of that. It will provide a vital boost to the local economy.”

Craig Gulliford, CEO of Creo Medical said:

“This is an exciting time for Creo Medical as we ramp up the manufacturing and commercialisation of multiple products, facilitating the treatment of more and more patients across the world through our pioneering technology.

“This Welsh Government funding will support that continued growth and ensure that we are able to build a team at our expanded headquarters and manufacturing base in Chepstow that will further cement Creo Medical and Wales’ place as global medtech leaders.”

SHARE

Creo Medical was founded in 2003 as MicroOncology Ltd by Professor Chris Hancock, initially to target the treatment of cancers through use of high frequency microwave energy and dynamic matching techniques. The business strategy subsequently evolved to develop minimally invasive electrosurgical endoscopic devices with wider applications, and was rebranded as Creo Medical in 2010 to reflect this.

The Company’s devices are each enabled by its multi-patented CROMA platform, powered by Kamaptive – Creo’s full-spectrum adaptive advanced energy source which optimises surgical capability and patient outcomes. The multi-patented Kamaptive technology provides clinicians with increased flexibility, precision and controlled surgical solutions.

CROMA is currently used to deliver bipolar radiofrequency energy for precise localised cutting and focused high frequency microwave energy for controlled coagulation and ablation via a single accessory port. Now in every-day in Europe, APAC and the US, this technology, combined with the Group’s range of unique electrosurgical devices, is facilitating a paradigm shift from surgery to endoscopic treatment – having already successfully removed cancerous lesions in the colon, stomach and elsewhere.

 

Related Articles

Business News Wales